Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$696,602
-$236,866 QoQ
Shares Held
1,560
-24.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST MANHATTAN CO. LLC. holds $4,696,275 across 10 Biotechnology names. VRTX ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMAC |
DiaMedica Therapeutics Inc.
|
455,000 | $3,080,350 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,560 | $696,602 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
11,146 | $308,744 | |
| 4 | TSHA |
Taysha Gene Therapies, Inc.
|
43,500 | $194,445 | |
| 5 | IMRX |
Immuneering Corp
|
24,245 | $127,771 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
28,998 | $101,782 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
14,000 | $63,000 | |
| 8 | ALDX |
Aldeyra Therapeutics, Inc.
|
34,745 | $58,719 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $696,602 | 1,560 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $933,468 | 2,059 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $618,791 | 1,580 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $705,642 | 1,585 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $753,895 | 1,555 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $626,198 | 1,555 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $730,175 | 1,570 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $728,859 | 1,555 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $649,587 | 1,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $604,638 | 1,486 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $542,474 | 1,560 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $546,516 | 1,553 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $480,481 | 1,525 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $450,208 | 1,559 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $448,787 | 1,550 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $493,132 | 1,750 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $456,697 | 1,750 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $384,300 | 1,750 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $317,432 | 1,750 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $352,852 | 1,750 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $462,013 | 2,150 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $531,765 | 2,250 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $620,705 | 2,281 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $683,680 | 2,355 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $554,423 | 2,330 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||